Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dendritic Cell Tumor Fusion Vaccine and GM-CSF in Renal Cell Cancer
NCT00458536Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Oct 2004
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
A Phase 2 trial of live DC-tumor fusion vaccine in renal cell carcinoma (RCC), sponsored by Beth Israel Deaconess Medical Center. Started Oct 2004; status: completed.
02
Drugs
live DC-tumor fusion vaccine
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00458536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458536.